Form Bio to Showcase AI-Driven AAV Gene Therapy Innovations at ASGCT 2024

On May 7-11, 2024, Form Bio will participate in the 27th annual meeting of the American Society of Gene and Cell Therapy (ASGCT) in Baltimore, Maryland. The company is set to deliver multiple vital presentations focusing on the advancement of gene therapy using artificial intelligence.

Among the key presentations, Dr. Amicia Elliott will discuss the enhancement of AAV vector design through advanced sequencing techniques. This session, along with other workshops and symposiums, aims to bridge the gap from preclinical developments to clinical success, particularly highlighting the role of AI in optimizing gene therapy constructs for improved safety, efficiency, and likelihood of success.

Additional engagements at the meeting include interactive workshops and "Meet the Expert" sessions, which promise further insights into AAV gene therapy, shared through collaboration with other industry leaders such as Solid Biosciences and Taysha Gene Therapies.